FORM 8-K
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

     Date of Report (Date of Earliest Event Reported): December 20, 2002 (December 19, 2002)

ENDO PHARMACEUTICALS HOLDINGS INC.

(Exact name of registrant as specified in its charter)
             
DELAWARE     39040     13-4022871
(State or other jurisdiction of incorporation)     (Commission File Number)     (I.R.S. Employer Identification No.)
             
100 Painters Drive            
Chadds Ford, Pennsylvania           19317
(Address of principal executive offices)           (Zip Code)

(610) 558-9800

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

 

TABLE OF CONTENTS

Item 5. Other Events.
Item 7. Financial Statements and Exhibits.
SIGNATURES
INDEX TO EXHIBITS
PRESS RELEASE
PRESS RELEASE
PRESS RELEASE
PRESS RELEASE

Table of Contents

Item 5.          Other Events.

     On December 19, 2002, the Registrant issued two press releases, copies of which are attached as Exhibit 99.1 and Exhibit 99.2 to this Report and are incorporated herein by reference. Further, on December 20, 2002, the Registrant issued two additional press releases, copies of which are attached as Exhibit 99.3 and Exhibit 99.4 to this Report and are incorporated herein by reference.

Item 7.           Financial Statements and Exhibits.

(a)   Financial Statements of Business Acquired.

      Not applicable.

(b)   Pro Forma Financial Information.

      Not applicable.

(c)   Exhibits.
     
Exhibit Number   Description
 
99.1   Press Release of Endo Pharmaceuticals Holdings Inc. dated December 19, 2002
99.2   Press Release of Endo Pharmaceuticals Holdings Inc. dated December 19, 2002
99.3   Press Release of Endo Pharmaceuticals Holdings Inc. dated December 20, 2002
99.4   Press Release of Endo Pharmaceuticals Holdings Inc. dated December 20, 2002

 

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

             
        ENDO PHARMACEUTICALS HOLDINGS INC.
        (Registrant)
             
        By:       /s/ Carol A. Ammon
           
            Name: Carol A. Ammon
            Title:   Chairman & Chief Executive Officer
             
Dated: December 20, 2002        

 

Table of Contents

INDEX TO EXHIBITS

     
Exhibit No.   Description
 
99.1   Press Release of Endo Pharmaceuticals Holdings Inc. dated December 19, 2002
99.2   Press Release of Endo Pharmaceuticals Holdings Inc. dated December 19, 2002
99.3   Press Release of Endo Pharmaceuticals Holdings Inc. dated December 20, 2002
99.4   Press Release of Endo Pharmaceuticals Holdings Inc. dated December 20, 2002